New

Glycosylated Peptide Market

2021

Glycosylated Peptide Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Erythropoietin, Monoclonal Antibodies, Others); Application (Blood Diseases, Oncology, Others) and Geography

| Report Code: TIPRE00003839 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Glycosylated Peptide Market 2028 By Product, Application and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Glycosylation of peptides is a covalent modification that has the potential to improve their physicochemical properties. It has a number of advantages, including the capacity to target specific tissues and organs, increased metabolic stability, increased bioavailability, improved receptor binding, and lower clearance rates. These are used in medicine to treat blood disorders, cancer, and other diseases.

MARKET SCOPE



The "Global Glycosylated Peptide Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the glycosylated peptide market with detailed market segmentation by product and application. The report provides key statistics on the market status of the leading glycosylated peptide market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on product the market is segmented as, erythropoietin, monoclonal antibodies and others.
  • Based on application the market is segmented as, blood diseases, oncology and others.

MARKET DYNAMICS


Drivers:



  • Rising prevalence of chronic disorders such as, cancers, genetic disorders.
  • Significant growth in biopharmaceutical industry aling and growth in R&D activities to develop more targeted glycosylated peptides.
  • Benefits of glycosylated peptides such as enhanced bioavailability, enhanced receptor binding are also expected to spur the market growth.

Restraints:



  • However, market growth is restrained by the complexities of manufacturing and the high cost of the active pharmaceutical ingredient (API).

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The glycosylated peptide market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the glycosylated peptide market in these regions.

IMPACT OF COVID-19 ON GLYCOSYLATED PEPTIDE MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the glycosylated peptide market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from glycosylated peptide market are anticipated to lucrative growth opportunities in the future with the rising demand for glycosylated peptide in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the glycosylated peptide market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Celltrion
  • Dr. Reddy's Laboratories Ltd
  • JPT Peptide Technologies
  • CPC Scientific Inc
  • Sussex Research Laboratories Inc
  • Bachem Americas, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Glycosylated Peptide Market - By Product
1.3.2 Glycosylated Peptide Market - By Application
1.3.3 Glycosylated Peptide Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. GLYCOSYLATED PEPTIDE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. GLYCOSYLATED PEPTIDE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. GLYCOSYLATED PEPTIDE MARKET - GLOBAL MARKET ANALYSIS
6.1. GLYCOSYLATED PEPTIDE - GLOBAL MARKET OVERVIEW
6.2. GLYCOSYLATED PEPTIDE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. GLYCOSYLATED PEPTIDE MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ERYTHROPOIETIN
7.3.1. Overview
7.3.2. Erythropoietin Market Forecast and Analysis
7.4. MONOCLONAL ANTIBODIES
7.4.1. Overview
7.4.2. Monoclonal Antibodies Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. GLYCOSYLATED PEPTIDE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BLOOD DISEASES
8.3.1. Overview
8.3.2. Blood Diseases Market Forecast and Analysis
8.4. ONCOLOGY
8.4.1. Overview
8.4.2. Oncology Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. GLYCOSYLATED PEPTIDE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Glycosylated Peptide Market Overview
9.1.2 North America Glycosylated Peptide Market Forecasts and Analysis
9.1.3 North America Glycosylated Peptide Market Forecasts and Analysis - By Product
9.1.4 North America Glycosylated Peptide Market Forecasts and Analysis - By Application
9.1.5 North America Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.1.5.1 United States Glycosylated Peptide Market
9.1.5.1.1 United States Glycosylated Peptide Market by Product
9.1.5.1.2 United States Glycosylated Peptide Market by Application
9.1.5.2 Canada Glycosylated Peptide Market
9.1.5.2.1 Canada Glycosylated Peptide Market by Product
9.1.5.2.2 Canada Glycosylated Peptide Market by Application
9.1.5.3 Mexico Glycosylated Peptide Market
9.1.5.3.1 Mexico Glycosylated Peptide Market by Product
9.1.5.3.2 Mexico Glycosylated Peptide Market by Application
9.2. EUROPE
9.2.1 Europe Glycosylated Peptide Market Overview
9.2.2 Europe Glycosylated Peptide Market Forecasts and Analysis
9.2.3 Europe Glycosylated Peptide Market Forecasts and Analysis - By Product
9.2.4 Europe Glycosylated Peptide Market Forecasts and Analysis - By Application
9.2.5 Europe Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Glycosylated Peptide Market
9.2.5.1.1 Germany Glycosylated Peptide Market by Product
9.2.5.1.2 Germany Glycosylated Peptide Market by Application
9.2.5.2 France Glycosylated Peptide Market
9.2.5.2.1 France Glycosylated Peptide Market by Product
9.2.5.2.2 France Glycosylated Peptide Market by Application
9.2.5.3 Italy Glycosylated Peptide Market
9.2.5.3.1 Italy Glycosylated Peptide Market by Product
9.2.5.3.2 Italy Glycosylated Peptide Market by Application
9.2.5.4 Spain Glycosylated Peptide Market
9.2.5.4.1 Spain Glycosylated Peptide Market by Product
9.2.5.4.2 Spain Glycosylated Peptide Market by Application
9.2.5.5 United Kingdom Glycosylated Peptide Market
9.2.5.5.1 United Kingdom Glycosylated Peptide Market by Product
9.2.5.5.2 United Kingdom Glycosylated Peptide Market by Application
9.2.5.6 Rest of Europe Glycosylated Peptide Market
9.2.5.6.1 Rest of Europe Glycosylated Peptide Market by Product
9.2.5.6.2 Rest of Europe Glycosylated Peptide Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Glycosylated Peptide Market Overview
9.3.2 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis
9.3.3 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Glycosylated Peptide Market
9.3.5.1.1 Australia Glycosylated Peptide Market by Product
9.3.5.1.2 Australia Glycosylated Peptide Market by Application
9.3.5.2 China Glycosylated Peptide Market
9.3.5.2.1 China Glycosylated Peptide Market by Product
9.3.5.2.2 China Glycosylated Peptide Market by Application
9.3.5.3 India Glycosylated Peptide Market
9.3.5.3.1 India Glycosylated Peptide Market by Product
9.3.5.3.2 India Glycosylated Peptide Market by Application
9.3.5.4 Japan Glycosylated Peptide Market
9.3.5.4.1 Japan Glycosylated Peptide Market by Product
9.3.5.4.2 Japan Glycosylated Peptide Market by Application
9.3.5.5 South Korea Glycosylated Peptide Market
9.3.5.5.1 South Korea Glycosylated Peptide Market by Product
9.3.5.5.2 South Korea Glycosylated Peptide Market by Application
9.3.5.6 Rest of Asia-Pacific Glycosylated Peptide Market
9.3.5.6.1 Rest of Asia-Pacific Glycosylated Peptide Market by Product
9.3.5.6.2 Rest of Asia-Pacific Glycosylated Peptide Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Glycosylated Peptide Market Overview
9.4.2 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis
9.4.3 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Glycosylated Peptide Market
9.4.5.1.1 South Africa Glycosylated Peptide Market by Product
9.4.5.1.2 South Africa Glycosylated Peptide Market by Application
9.4.5.2 Saudi Arabia Glycosylated Peptide Market
9.4.5.2.1 Saudi Arabia Glycosylated Peptide Market by Product
9.4.5.2.2 Saudi Arabia Glycosylated Peptide Market by Application
9.4.5.3 U.A.E Glycosylated Peptide Market
9.4.5.3.1 U.A.E Glycosylated Peptide Market by Product
9.4.5.3.2 U.A.E Glycosylated Peptide Market by Application
9.4.5.4 Rest of Middle East and Africa Glycosylated Peptide Market
9.4.5.4.1 Rest of Middle East and Africa Glycosylated Peptide Market by Product
9.4.5.4.2 Rest of Middle East and Africa Glycosylated Peptide Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Glycosylated Peptide Market Overview
9.5.2 South and Central America Glycosylated Peptide Market Forecasts and Analysis
9.5.3 South and Central America Glycosylated Peptide Market Forecasts and Analysis - By Product
9.5.4 South and Central America Glycosylated Peptide Market Forecasts and Analysis - By Application
9.5.5 South and Central America Glycosylated Peptide Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Glycosylated Peptide Market
9.5.5.1.1 Brazil Glycosylated Peptide Market by Product
9.5.5.1.2 Brazil Glycosylated Peptide Market by Application
9.5.5.2 Argentina Glycosylated Peptide Market
9.5.5.2.1 Argentina Glycosylated Peptide Market by Product
9.5.5.2.2 Argentina Glycosylated Peptide Market by Application
9.5.5.3 Rest of South and Central America Glycosylated Peptide Market
9.5.5.3.1 Rest of South and Central America Glycosylated Peptide Market by Product
9.5.5.3.2 Rest of South and Central America Glycosylated Peptide Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. GLYCOSYLATED PEPTIDE MARKET, KEY COMPANY PROFILES
11.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. SANDOZ INTERNATIONAL GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. F. HOFFMANN-LA ROCHE LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CELLTRION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. DR. REDDY'S LABORATORIES LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JPT PEPTIDE TECHNOLOGIES.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. CPC SCIENTIFIC INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BACHEM AMERICAS, INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SUSSEX RESEARCH LABORATORIES INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
"
The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Sandoz International GmbH
3. Pfizer Inc.
4. F. Hoffmann-La Roche Ltd
5. Celltrion
6. Dr. Reddy's Laboratories Ltd
7. JPT Peptide Technologies.
8. CPC Scientific Inc
9. Bachem Americas, Inc
10. Sussex Research Laboratories Inc.
TIPRE00003839
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.